Medirom Healthcare Technologies Stock Performance

MRM Stock  USD 1.41  0.05  3.68%   
The company secures a Beta (Market Risk) of 0.4, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Medirom Healthcare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medirom Healthcare is expected to be smaller as well. At this point, Medirom Healthcare has a negative expected return of -0.62%. Please make sure to verify Medirom Healthcare's treynor ratio, as well as the relationship between the kurtosis and day typical price , to decide if Medirom Healthcare performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Medirom Healthcare Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2026. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
1
MEDIROM Mother Labs Partners with TD SYNNEX to Accelerate National Adoption of MOTHER Bracelet and REMONY
12/04/2025
2
MEDIROM Healthcare Technologies Completes JPY400 Million Bond Issuance - TipRanks
12/15/2025
3
MEDIROM Healthcare Technologies Trading 2.8 percent Higher - Heres Why - MarketBeat
12/23/2025
4
MEDIROM to Build Worlds Proof of Human Network Across Japan Under New Service Pact - The Globe and Mail
12/30/2025
5
Disposition of 17000 shares by Cohen Edward H of Medirom Healthcare at 16.0 subject to Rule 16b-3
12/31/2025
6
Acquisition by Cohen Edward H of 2500 shares of Medirom Healthcare at 3.1 subject to Rule 16b-3
01/08/2026
7
MEDIROM Healthcare Technologies Shares Down 2.7 percent - Whats Next - MarketBeat
01/13/2026
8
Its Down 26 percent But MEDIROM Healthcare Technologies Inc. Could Be Riskier Than It Looks -
02/03/2026
Begin Period Cash Flow106.3 M
Total Cashflows From Investing Activities361.4 M

Medirom Healthcare Relative Risk vs. Return Landscape

If you would invest  201.00  in Medirom Healthcare Technologies on November 21, 2025 and sell it today you would lose (65.00) from holding Medirom Healthcare Technologies or give up 32.34% of portfolio value over 90 days. Medirom Healthcare Technologies is generating negative expected returns assuming volatility of 2.7841% on return distribution over 90 days investment horizon. In other words, 25% of stocks are less volatile than Medirom, and above 99% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Medirom Healthcare is expected to under-perform the market. In addition to that, the company is 3.73 times more volatile than its market benchmark. It trades about -0.22 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.17 per unit of volatility.

Medirom Healthcare Target Price Odds to finish over Current Price

The tendency of Medirom Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 1.41 90 days 1.41 
more than 94.0
Based on a normal probability distribution, the odds of Medirom Healthcare to move above the current price in 90 days from now is more than 94.0 (This Medirom Healthcare Technologies probability density function shows the probability of Medirom Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Medirom Healthcare has a beta of 0.4. This indicates as returns on the market go up, Medirom Healthcare average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Medirom Healthcare Technologies will be expected to be much smaller as well. Additionally Medirom Healthcare Technologies has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Medirom Healthcare Price Density   
       Price  

Predictive Modules for Medirom Healthcare

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Medirom Healthcare. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.061.244.02
Details
Intrinsic
Valuation
LowRealHigh
0.112.295.07
Details
Naive
Forecast
LowNextHigh
0.031.324.10
Details
1 Analysts
Consensus
LowTargetHigh
4.665.125.69
Details

Medirom Healthcare Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Medirom Healthcare is not an exception. The market had few large corrections towards the Medirom Healthcare's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Medirom Healthcare Technologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Medirom Healthcare within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.64
β
Beta against Dow Jones0.40
σ
Overall volatility
0.29
Ir
Information ratio -0.23

Medirom Healthcare Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Medirom Healthcare for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Medirom Healthcare can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Medirom Healthcare generated a negative expected return over the last 90 days
Medirom Healthcare may become a speculative penny stock
Medirom Healthcare has high likelihood to experience some financial distress in the next 2 years
Medirom Healthcare Technologies has 3.96 B in debt. Medirom Healthcare has a current ratio of 0.35, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Nevertheless, prudent borrowing could serve as an effective mechanism for Medirom to finance growth opportunities yielding strong returns.
Medirom Healthcare Technologies has about 354.95 M in cash with (1.33 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 72.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Medirom Healthcare has a poor financial position based on the latest SEC disclosures
Roughly 26.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Its Down 26 percent But MEDIROM Healthcare Technologies Inc. Could Be Riskier Than It Looks -

Medirom Healthcare Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Medirom Stock often depends not only on the future outlook of the current and potential Medirom Healthcare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medirom Healthcare's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding5.9 M
Cash And Short Term Investments335.6 M

Medirom Healthcare Fundamentals Growth

Medirom Stock prices reflect investors' perceptions of the future prospects and financial health of Medirom Healthcare, and Medirom Healthcare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medirom Stock performance.

About Medirom Healthcare Performance

By examining Medirom Healthcare's fundamental ratios, stakeholders can obtain critical insights into Medirom Healthcare's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Medirom Healthcare is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 8.23  8.64 
Return On Tangible Assets 0.02  0.02 
Return On Capital Employed(0.01)(0.01)
Return On Assets 0.02  0.02 
Return On Equity 0.14  0.15 

Things to note about Medirom Healthcare performance evaluation

Checking the ongoing alerts about Medirom Healthcare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medirom Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Medirom Healthcare generated a negative expected return over the last 90 days
Medirom Healthcare may become a speculative penny stock
Medirom Healthcare has high likelihood to experience some financial distress in the next 2 years
Medirom Healthcare Technologies has 3.96 B in debt. Medirom Healthcare has a current ratio of 0.35, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Nevertheless, prudent borrowing could serve as an effective mechanism for Medirom to finance growth opportunities yielding strong returns.
Medirom Healthcare Technologies has about 354.95 M in cash with (1.33 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 72.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Medirom Healthcare has a poor financial position based on the latest SEC disclosures
Roughly 26.0% of the company outstanding shares are owned by corporate insiders
Latest headline from news.google.com: Its Down 26 percent But MEDIROM Healthcare Technologies Inc. Could Be Riskier Than It Looks -
Evaluating Medirom Healthcare's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Medirom Healthcare's stock performance include:
  • Analyzing Medirom Healthcare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medirom Healthcare's stock is overvalued or undervalued compared to its peers.
  • Examining Medirom Healthcare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Medirom Healthcare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medirom Healthcare's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Medirom Healthcare's stock. These opinions can provide insight into Medirom Healthcare's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Medirom Healthcare's stock performance is not an exact science, and many factors can impact Medirom Healthcare's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Will Health Care Providers & Services sector continue expanding? Could Medirom diversify its offerings? Factors like these will boost the valuation of Medirom Healthcare. Expected growth trajectory for Medirom significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Medirom Healthcare data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
0.278
Earnings Share
0.39
Revenue Per Share
1.2 K
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.02)
Understanding Medirom Healthcare requires distinguishing between market price and book value, where the latter reflects Medirom's accounting equity. The concept of intrinsic value - what Medirom Healthcare's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Medirom Healthcare's price substantially above or below its fundamental value.
Understanding that Medirom Healthcare's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Medirom Healthcare represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Medirom Healthcare's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.